Investing.com - Cue Biopharma (NASDAQ: CUE) reported second quarter EPS of $-0.090, $0.05 better than the analyst estimate of $-0.140. Revenue for the quarter came in at $2.95M versus the consensus ...

The online-comic platform said that the team-up will see comics from the Disney, Marvel, 20th Century Studios, and Star Wars brands coming to Webtoon’s mobile vertical-scroll format. Continue ...

Highlights,Vice President Amy A. Samford increased stock in Kronos Worldwide Inc,Shares traded recently on the New York Stock ...

Highlights,Riley Exploration Permian insider Corey Neil Riley executed a sale of shares at an average market rate.,The ...

Highlights,Morgan Stanley raised the valuation estimate for Viavi Solutions.,The company operates in the communications ...

Highlights,Market pricing shifted toward expectations of policy easing following recent price data.,Consumer price signals ...

Highlights,TNL Mediagene as operates a diverse portfolio of media brands across Asia’s digital landscape.,The company ...

Highlights,Major technology and semiconductor firms shape market dynamics through product and platform leadership.,Demand for ...

Artivion, Inc. operates within the medical equipment industry, a segment closely tracked on indices such as the NYSE ...

Highlights,Major benchmarks moved higher following a key inflation update that was broadly in line with ...

Veru Inc shows promise but remains affected by Nasdaq Composite trends. Read the latest analysis on market performance.

Highlights,Nu Skin Enterprises experiences notable share increase after announcing.,Scheduled with record date and ex- date ...